Cancer
At the Kolling Institute, our cancer research aims to identify and overcome the factors that drive cancer development so that we can improve patient outcomes. We have a number of cancer research teams with different expertise, specialising in chemotherapy resistance, immunotherapies, genetics, epigenetics, diagnostic services and clinical trials. Importantly, these teams have access to an active tissue bank and the latest equipment.
Our cancer research rapidly implements laboratory findings into clinical practice and is supported by the Cancer Institute Translational Centre, Sydney Vital. By bringing together research scientists, clinicians and allied health professionals, we are able to combine innovative and cutting edge research with personalised treatment strategies for cancer patients.
Find out more about:
Bill Walsh Translational Cancer Research Laboratory
Bowel Cancer and Biomarker Research Lab
Breast Cancer Research
Cancer Genetics Laboratory
Kolling Institute Tumour Bank
Events, News and Seminars
Researchers to join leading cancer care centres in exciting new trial
Posted on: 04 March, 2022
Researchers from the Kolling Institute and Royal North Shore Hospital will help drive a new project ..... Read more
Category: Funding support, Research Excellence
Exciting study to investigate new treatment for acute myeloid leukaemia
Posted on: 28 February, 2022
The Cancer Council NSW today announced funding for a new stem cell team at the Kolling Institute to ..... Read more
Category: Funding support, Research Excellence
New cutting-edge technology coming to the Kolling
Posted on: 09 February, 2022
The Kolling is set to be one of the first institutes in New South Wales to introduce new world-leadi..... Read more
Category: Research Excellence, World-leading technology